Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 171

1.

[Austrian Consensus on High Blood Pressure 2019].

Weber T, Arbeiter K, Ardelt F, Auer J, Aufricht C, Brandt MC, Dichtl W, Ferrari J, Föger B, Henkel M, Hohenstein-Scheibenecker K, Horn S, Kautzky-Willer A, Kepplinger E, Knoflach M, Koppelstätter C, Mache C, Marschang P, Mayer G, Metzler B, Oberbauer R, Obermair F, Obermayer-Pietsch B, Perl S, Pilz S, Prischl FC, Podczeck-Schweighofer A, Rebhandl E, Rohla M, Roller-Wirnsberger R, Saely CH, Siostrzonek P, Slany J, Stoschitzky K, Waldegger S, Wenzel RR, Weiss T, Wirnsberger G, Winhofer-Stöckl Y, Zweiker D, Zweiker R, Watschinger B; Österreichische Gesellschaft für Hypertensiologie; Österreichische Atherosklerosegesellschaft; Österreichische Diabetes Gesellschaft; Österreichische Gesellschaft für Internistische Angiologie; Österreichische Gesellschaft für Nephrologie; Österreichische Kardiologische Gesellschaft; Österreichische Gesellschaft für Neurologie; Österreichische Schlaganfall-Gesellschaft; Österr. Gesellschaft für Allgemeinmedizin; Österr. Gesellschaft für Geriatrie; Österreichische Gesellschaft für Endokrinologie und Stoffwechsel; Österreichische Gesellschaft für Innere Medizin; Österreichische Gesellschaft für Kinder- und Jugendheilkunde.

Wien Klin Wochenschr. 2019 Nov;131(Suppl 6):489-590. doi: 10.1007/s00508-019-01565-0. German.

PMID:
31792659
2.

Blood pressure changes after renal denervation are more pronounced in women and nondiabetic patients: findings from the Austrian Transcatheter Renal Denervation Registry.

Zweiker D, Lambert T, Steinwender C, Weber T, Suppan M, Brussee H, Niederl E, Koppelstaetter C, Kerschbaum J, Watschinger B, Hohenstein-Scheibenecker K, Reindl-Schwaighofer R, Sturmberger T, Kindslehner C, Weiss TW, Rohla M, Gruener P, Maister P, Auer J, Dechant C, Sykora J, Krismer C, Glaser S, Zirlik A, Zweiker R.

J Hypertens. 2019 Nov;37(11):2290-2297. doi: 10.1097/HJH.0000000000002190.

PMID:
31335512
3.

Comparative effectiveness of different antihypertensive agents in kidney transplantation: a systematic review and meta-analysis.

Pisano A, Bolignano D, Mallamaci F, D'Arrigo G, Halimi JM, Persu A, Wuerzner G, Sarafidis P, Watschinger B, Burnier M, Zoccali C.

Nephrol Dial Transplant. 2019 May 29. pii: gfz092. doi: 10.1093/ndt/gfz092. [Epub ahead of print]

PMID:
31143926
4.

[Individualising antihypertensive therapy in patients with diabetes. A guideline by the Austrian Diabetes Association (Update 2019)].

Schernthaner G, Saely CH, Schernthaner GH, Watschinger B, Drexel H.

Wien Klin Wochenschr. 2019 May;131(Suppl 1):124-135. doi: 10.1007/s00508-019-1460-2. Review. German.

PMID:
30980142
5.

Pre-existing malignancies in renal transplant candidates-time to reconsider waiting times.

Watschinger B, Budde K, Crespo M, Heemann U, Hilbrands L, Maggiore U, Mariat C, Oberbauer R, Oniscu GC, Peruzzi L, Sorensen SS, Viklicky O, Abramowicz D.

Nephrol Dial Transplant. 2019 Mar 4. pii: gfz026. doi: 10.1093/ndt/gfz026. [Epub ahead of print]

PMID:
30830155
6.

Standard work-up of the low-risk kidney transplant candidate: a European expert survey of the ERA-EDTA Developing Education Science and Care for Renal Transplantation in European States Working Group.

Maggiore U, Abramowicz D, Budde K, Crespo M, Mariat C, Oberbauer R, Pascual J, Peruzzi L, Schwartz Sorensen S, Viklicky O, Watschinger B, Oniscu GC, Heemann U, Hilbrands LB; ERA-EDTA DESCARTES Working Group.

Nephrol Dial Transplant. 2019 Sep 1;34(9):1605-1611. doi: 10.1093/ndt/gfy391.

PMID:
30629182
7.

Acetylsalicylic acid decreases clotting in combination with enoxaparin during haemodialysis in vitro.

Samaha E, Schwameis M, Schranz S, Watschinger B, Buchmüller A, Jilma B.

Nephrol Dial Transplant. 2019 Mar 1;34(3):509-515. doi: 10.1093/ndt/gfy229.

PMID:
30053218
8.

Optimizing hypertension management in renal transplantation: a call to action.

Halimi JM, Persu A, Sarafidis PA, Burnier M, Abramowicz D, Sautenet B, Oberbauer R, Mallamaci F, London G, Rossignol P, Wuerzner G, Watschinger B, Zoccali C.

Nephrol Dial Transplant. 2017 Dec 1;32(12):1959-1962. doi: 10.1093/ndt/gfx283. No abstract available.

PMID:
29099945
9.

Optimizing hypertension management in renal transplantation: a call to action.

Halimi JM, Persu A, Sarafidis PA, Burnier M, Abramowicz D, Sautenet B, Oberbauer R, Mallamaci F, London G, Rossignol P, Wuerzner G, Watschinger B, Zoccali C; European Renal, Cardiovascular Medicine (EURECA-m), the transplant DESCARTES working group of the European Renal Association-European Dialysis, Transplant Association (ERA-EDTA), the Working Group ‘Hypertension, Kidney’ of the European Society of Hypertension (ESH); the EKITA committee of the European Society of Organ Transplantation (ESOT), FCRIN INI-CRCT Cardiovascular, Renal Clinical Trialists.

J Hypertens. 2017 Dec;35(12):2335-2338. doi: 10.1097/HJH.0000000000001586. No abstract available. Erratum in: J Hypertens. 2019 Aug;37(8):1734.

PMID:
29095226
10.

Effects of Renal Denervation Documented in the Austrian National Multicentre Renal Denervation Registry.

Zweiker D, Lambert T, Steinwender C, Weber T, Suppan M, Brussee H, Koppelstätter C, Kerschbaum J, Watschinger B, Hohenstein-Scheibenecker K, Reindl-Schwaighofer R, Sturmberger T, Kindslehner C, Weiss TW, Rohla M, Gruener P, Maister P, Auer J, Dechant C, Sykora J, Krismer C, Glaser S, Zweiker R.

PLoS One. 2016 Aug 16;11(8):e0161250. doi: 10.1371/journal.pone.0161250. eCollection 2016.

11.

Hypertension and coronary artery disease: epidemiology, physiology, effects of treatment, and recommendations : A joint scientific statement from the Austrian Society of Cardiology and the Austrian Society of Hypertension.

Weber T, Lang I, Zweiker R, Horn S, Wenzel RR, Watschinger B, Slany J, Eber B, Roithinger FX, Metzler B.

Wien Klin Wochenschr. 2016 Jul;128(13-14):467-79. doi: 10.1007/s00508-016-0998-5. Epub 2016 Jun 9.

PMID:
27278135
12.

DAA-based antiviral treatment of patients with chronic hepatitis C in the pre- and postkidney transplantation setting.

Beinhardt S, Al Zoairy R, Ferenci P, Kozbial K, Freissmuth C, Stern R, Stättermayer AF, Stauber R, Strasser M, Zoller H, Watschinger B, Schmidt A, Trauner M, Hofer H, Maieron A.

Transpl Int. 2016 Sep;29(9):999-1007. doi: 10.1111/tri.12799. Epub 2016 Jul 7.

13.

Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications: A joint position statement issued by eight medical societies. 2016 update.

Toplak H, Ludvik B, Lechleitner M, Dieplinger H, Föger B, Paulweber B, Weber T, Watschinger B, Horn S, Wascher TC, Drexel H, Brodmann M, Pilger E, Rosenkranz A, Pohanka E, Oberbauer R, Traindl O, Roithinger FX, Metzler B, Haring HP, Kiechl S.

Wien Klin Wochenschr. 2016 Apr;128 Suppl 2:S216-28. doi: 10.1007/s00508-016-0993-x.

14.

[Antihypertensive therapy in diabetes mellitus: Guidelines of the Austrian Diabetes Association 2016].

Schernthaner G, Drexel H, Rosenkranz A, Schernthaner GH, Watschinger B.

Wien Klin Wochenschr. 2016 Apr;128 Suppl 2:S62-7. doi: 10.1007/s00508-015-0924-2. Review. German.

PMID:
27052224
15.

Long-term outcome of belatacept therapy in de novo kidney transplant recipients - a case-match analysis.

Schwarz C, Mayerhoffer S, Berlakovich GA, Steininger R, Soliman T, Watschinger B, Böhmig GA, Eskandary F, König F, Mühlbacher F, Wekerle T.

Transpl Int. 2015 Jul;28(7):820-7. doi: 10.1111/tri.12544. Epub 2015 Mar 6.

16.

[Austrian Society of Hypertension].

Watschinger B.

Wien Klin Wochenschr. 2014 Apr;126(7-8):254-5. doi: 10.1007/s00508-014-0511-y. German. No abstract available.

PMID:
24668186
17.

The MAINTAIN study--managing hemoglobin variability with darbepoetin alfa in dialysis patients experiencing a severe drop in hemoglobin.

Watschinger B, Salmhofer H, Horn S, Neyer U, Wiesinger T, Wiesholzer M, Erb H, Jaeger C, Hemetsberger M, Rosenkranz AR.

Wien Klin Wochenschr. 2013 Feb;125(3-4):71-82. doi: 10.1007/s00508-012-0311-1. Epub 2013 Jan 9.

PMID:
23299452
18.

[Antihypertensive therapy in diabetes mellitus - 2012 guidelines of the Austrian Diabetes Association].

Schernthaner G, Drexel H, Rosenkranz AR, Schernthaner GH, Watschinger B; Ausrian Diabetes Association.

Wien Klin Wochenschr. 2012 Dec;124 Suppl 2:23-7. doi: 10.1007/s00508-012-0270-6. German.

PMID:
23250458
19.

Clinical application of interventional renal sympathetic denervation: recommendations of the Austrian Society of Hypertension 2012.

Weber T, Zweiker R, Watschinger B, Grüner P, Koppelstätter C, Brandt MC, Horina J, Brussee H, Hohenstein K, Lambert T, Auer J, Hoppe UC.

Wien Klin Wochenschr. 2012 Nov;124(21-22):789-98. doi: 10.1007/s00508-012-0257-3. Epub 2012 Nov 27.

PMID:
23184070
20.

Anemia in solid organ transplantation.

Małyszko J, Watschinger B, Przybyłowski P, Durlik M.

Ann Transplant. 2012 Apr-Jun;17(2):86-100. Review.

PMID:
22743727
21.

Anemia and erythrocytosis in patients after kidney transplantation.

Malyszko J, Oberbauer R, Watschinger B.

Transpl Int. 2012 Oct;25(10):1013-23. doi: 10.1111/j.1432-2277.2012.01513.x. Epub 2012 Jun 21. Review.

22.

[Hypertension and nutrition. Position paper of the Austrian Nutrition Society].

Dorner TE, Genser D, Krejs G, Slany J, Watschinger B, Ekmekcioglu C, Rieder A.

Herz. 2013 Mar;38(2):153-62. doi: 10.1007/s00059-012-3613-1. Epub 2012 May 17. Review. German.

PMID:
22588364
23.

Recurrent circumflex artery embolization due to a free-floating fibroelastoma at the aortic valve.

Gremmel T, Pfaffenberger S, Binder T, Kocher A, Watschinger B.

Ann Thorac Surg. 2011 May;91(5):1626. doi: 10.1016/j.athoracsur.2010.09.062. No abstract available.

PMID:
21524483
24.

Effective use of cinacalcet for the treatment of secondary hyperparathyroidism in Austrian dialysis patients--results of the Austrian cohort of the ECHO study.

Zitt E, Jäger C, Rosenkranz AR, Eigner M, Kodras K, Kovarik J, Graf H, Pétavy F, Horn S, Watschinger B.

Wien Klin Wochenschr. 2011 Jan;123(1-2):45-52. doi: 10.1007/s00508-010-1515-x. Epub 2011 Jan 21.

PMID:
21253777
25.

Prevalence of NSF following intravenous gadolinium-contrast media administration in dialysis patients with endstage renal disease.

Heinz-Peer G, Neruda A, Watschinger B, Vychytil A, Geusau A, Haumer M, Weber M.

Eur J Radiol. 2010 Oct;76(1):129-34. doi: 10.1016/j.ejrad.2009.06.028. Epub 2009 Jul 19.

PMID:
19619969
26.

[Laudation for Prof. Dr. Gerhard Giebisch on the occasion of the bestowal of the honorary membership of the OGIM].

Watschinger B.

Wien Klin Wochenschr. 2008;120(15-16):514-7. doi: 10.1007/s00508-008-1041-2. German. No abstract available.

PMID:
18820858
27.

[Hypertension and the kidney].

Hohenstein K, Watschinger B.

Wien Med Wochenschr. 2008;158(13-14):359-64. doi: 10.1007/s10354-008-0558-3. Review. German.

PMID:
18677585
28.

Pre-transplant predictors of cerebrovascular events after kidney transplantation.

Aull-Watschinger S, Konstantin H, Demetriou D, Schillinger M, Habicht A, Hörl WH, Watschinger B.

Nephrol Dial Transplant. 2008 Apr;23(4):1429-35. Epub 2007 Nov 28.

PMID:
18045824
29.

Analysis of liver function in renal transplant recipients undergoing C2-monitoring for cyclosporine.

Hecking M, Kainz A, Schillinger M, Posch C, Birsan T, Rasoul-Rockenschaub S, Böhmig GA, Schmaldienst S, Watschinger B, Hörl WH, Mühlbacher F, Säemann MD.

Transpl Int. 2008 Mar;21(3):223-33. Epub 2007 Sep 28.

30.

Antibody-mediated rejection.

Akalin E, Watschinger B.

Semin Nephrol. 2007 Jul;27(4):393-407. Review.

PMID:
17616272
31.

Alemtuzumab (Campath-1H) induction therapy and dendritic cells: Impact on peripheral dendritic cell repertoire in renal allograft recipients.

Kirsch BM, Haidinger M, Zeyda M, Böhmig GA, Tombinsky J, Mühlbacher F, Watschinger B, Hörl WH, Säemann MD.

Transpl Immunol. 2006 Nov;16(3-4):254-7. Epub 2006 Oct 4.

PMID:
17138063
32.

Impairment of T cell interactions with antigen-presenting cells by immunosuppressive drugs reveals involvement of calcineurin and NF-kappaB in immunological synapse formation.

Zeyda M, Geyeregger R, Poglitsch M, Weichhart T, Zlabinger GJ, Koyasu S, Hörl WH, Stulnig TM, Watschinger B, Saemann MD.

J Leukoc Biol. 2007 Jan;81(1):319-27. Epub 2006 Oct 12.

PMID:
17038582
33.

Endothelial progenitor cells in kidney transplant recipients.

Steiner S, Winkelmayer WC, Kleinert J, Grisar J, Seidinger D, Kopp CW, Watschinger B, Minar E, Hörl WH, Födinger M, Sunder-Plassmann G.

Transplantation. 2006 Feb 27;81(4):599-606.

PMID:
16495809
34.

The novel immunosuppressant FK778 inhibits formation of the immunologic Synapse.

Zeyda M, Geyeregger R, Poglitsch M, Watschinger B, Hörl WH, Stulnig TM, Säemann MD.

Transplant Proc. 2005 May;37(4):1970-1.

PMID:
15919521
35.

The malononitrilamide FK778 inhibits activation of NF-kappaB in human dendritic cells.

Zeyda M, Stuhlmeier KM, Kirsch B, Watschinger B, Hörl WH, Stulnig TM, Säemann MD.

Transplant Proc. 2005 May;37(4):1968-9.

PMID:
15919520
36.

The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function.

Kirsch BM, Zeyda M, Stuhlmeier K, Grisar J, Smolen JS, Watschinger B, Stulnig TM, Hörl WH, Zlabinger GJ, Säemann MD.

Arthritis Res Ther. 2005;7(3):R694-703. Epub 2005 Apr 1.

37.

[Renal sequelae of sympathetic hyperactivity].

Watschinger B, Habicht A.

Wien Med Wochenschr. 2004;154 Spec No 1(1):7-9. German. No abstract available.

PMID:
15346546
38.

Donor heme oxygenase-1 genotype is associated with renal allograft function.

Exner M, Böhmig GA, Schillinger M, Regele H, Watschinger B, Hörl WH, Raith M, Mannhalter C, Wagner OF.

Transplantation. 2004 Feb 27;77(4):538-42.

PMID:
15084931
39.

Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates.

Kerjaschki D, Regele HM, Moosberger I, Nagy-Bojarski K, Watschinger B, Soleiman A, Birner P, Krieger S, Hovorka A, Silberhumer G, Laakkonen P, Petrova T, Langer B, Raab I.

J Am Soc Nephrol. 2004 Mar;15(3):603-12.

40.

[Sympathetic overactivity and the kidney].

Habicht A, Watschinger B.

Wien Klin Wochenschr. 2003 Sep 30;115(17-18):634-40. Review. German.

PMID:
14603734
41.

Treatment of hypertension in renal transplant recipients.

Tylicki L, Habicht A, Watschinger B, Hörl WH.

Curr Opin Urol. 2003 Mar;13(2):91-8. Review.

PMID:
12584467
42.

A case of severe C4d-positive kidney allograft dysfunction in the absence of histomorphologic features of rejection.

Habicht A, Regele H, Exner M, Soleiman A, Hörl WH, Watschinger B, Derfler K, Böhmig GA.

Wien Klin Wochenschr. 2002 Nov 30;114(21-22):945-8.

PMID:
12528329
43.

Pneumocystis carinii in a patient with hypercalcemia and renal failure secondary to sarcoidosis.

Krebs M, Watschinger B, Brunner C, Hassl A, Base W.

Wien Klin Wochenschr. 2002 Sep 30;114(17-18):785-8.

PMID:
12416284
44.

Derivation of nephrogenic adenomas from renal tubular cells in kidney-transplant recipients.

Mazal PR, Schaufler R, Altenhuber-Müller R, Haitel A, Watschinger B, Kratzik C, Krupitza G, Regele H, Meisl FT, Zechner O, Kerjaschki D, Susani M.

N Engl J Med. 2002 Aug 29;347(9):653-9. Erratum in: N Engl J Med 2002 Oct 24;347(17):1390.

45.

Capillary C4d deposition as a marker of humoral immunity in renal allograft rejection.

Watschinger B, Pascual M.

J Am Soc Nephrol. 2002 Sep;13(9):2420-3. Review. No abstract available.

46.

Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection.

Regele H, Böhmig GA, Habicht A, Gollowitzer D, Schillinger M, Rockenschaub S, Watschinger B, Kerjaschki D, Exner M.

J Am Soc Nephrol. 2002 Sep;13(9):2371-80.

47.

Chronic hepatitis B virus infection in renal transplant recipients.

Kletzmayr J, Watschinger B.

Semin Nephrol. 2002 Jul;22(4):375-89. Review.

PMID:
12118403
48.

Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury.

Böhmig GA, Exner M, Habicht A, Schillinger M, Lang U, Kletzmayr J, Säemann MD, Hörl WH, Watschinger B, Regele H.

J Am Soc Nephrol. 2002 Apr;13(4):1091-9.

49.

Acute humoral renal allograft rejection.

Böhmig GA, Exner M, Watschinger B, Regele H.

Curr Opin Urol. 2002 Mar;12(2):95-9. Review.

PMID:
11859254
50.

A patient with evidence of two underlying diseases causing hypercalcaemia.

Schmaldienst S, Dittrich E, Pietschmann P, Niederle B, Becherer A, Watschinger B.

Nephrol Dial Transplant. 2001 Dec;16(12):2423-5. No abstract available.

PMID:
11733639

Supplemental Content

Loading ...
Support Center